标题
Management of cytomegalovirus infection in haemopoietic stem cell transplantation
作者
关键词
-
出版物
BRITISH JOURNAL OF HAEMATOLOGY
Volume 162, Issue 1, Pages 25-39
出版商
Wiley
发表日期
2013-05-06
DOI
10.1111/bjh.12363
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prevention of Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Valganciclovir: Single Center Experience
- (2014) P. Rzepecki et al. JOURNAL OF CHEMOTHERAPY
- DEFINITION OF CLINICAL THRESHOLD FOR CMV REAL-TIME PCR AFTER COMPARISON WITH PP65 ANTIGENAEMIA AND CLINICAL DATA
- (2014) F. Mullier et al. ACTA CLINICA BELGICA
- Efficiency and Risk Factors for CMV Transmission in Seronegative Hematopoietic Stem Cell Recipients
- (2012) Steven A. Pergam et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A perspective on the selection of unrelated donors and cord blood units for transplantation
- (2012) S. R. Spellman et al. BLOOD
- Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant
- (2012) Robert Chiesa et al. BRITISH JOURNAL OF HAEMATOLOGY
- An International Multicenter Performance Analysis of Cytomegalovirus Load Tests
- (2012) H. H. Hirsch et al. CLINICAL INFECTIOUS DISEASES
- Transporter-Targeted Lipid Prodrugs of Cyclic Cidofovir: A Potential Approach for the Treatment of Cytomegalovirus Retinitis
- (2012) Mitan R. Gokulgandhi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients
- (2012) Y.-J. Kim et al. Transplant Infectious Disease
- Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients
- (2011) Martha T van der Beek et al. ANTIVIRAL THERAPY
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
- (2011) Isabel Ruiz-Camps et al. ANTIVIRAL THERAPY
- Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin
- (2011) Craig Sauter et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CMV Infection after Transplant from Cord Blood Compared to Other Alternative Donors: The Importance of Donor-Negative CMV Serostatus
- (2011) Małgorzata Mikulska et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation
- (2011) Abraham Guerrero et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
- (2011) A. H. Elmaagacli et al. BLOOD
- Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
- (2011) F. Milano et al. BLOOD
- Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation
- (2011) Patrick J. Hanley et al. CYTOTHERAPY
- Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
- (2011) Uluhan Sili et al. CYTOTHERAPY
- Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- (2011) Per Ljungman et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quantitation of Plasma Cytomegalovirus DNAemia in Allogeneic Stem Cell Transplant Recipients
- (2011) D. Bravo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Paradoxical Rising Cytomegalovirus Antigenemia during Preemptive Ganciclovir Therapy in Hematopoietic Stem Cell Transplant Recipients: Incidence, Risk Factors, and Clinical Outcomes
- (2011) S.-Y. Park et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cytomegalovirus quantification: Where to next in optimising patient management?
- (2011) Claire Atkinson et al. JOURNAL OF CLINICAL VIROLOGY
- Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients
- (2011) José Blanquer et al. JOURNAL OF MEDICAL VIROLOGY
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
- (2011) T. Goldner et al. JOURNAL OF VIROLOGY
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
- (2011) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Leflunomide for cytomegalovirus: bench to bedside
- (2011) B. Chacko et al. Transplant Infectious Disease
- Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature
- (2011) J.S. Chawla et al. Transplant Infectious Disease
- Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation
- (2011) Peter A. Andrews et al. TRANSPLANTATION
- Oral Hexadecyloxypropyl-Cidofovir Therapy in Pregnant Guinea Pigs Improves Outcome in the Congenital Model of Cytomegalovirus Infection
- (2010) Fernando J. Bravo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Donor Serostatus Has an Impact on Cytomegalovirus-Specific Immunity, Cytomegaloviral Disease Incidence, and Survival in Seropositive Hematopoietic Cell Transplant Recipients
- (2010) Alejandra Ugarte-Torres et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An International Comparison of Current Strategies to Prevent Herpesvirus and Fungal Infections in Hematopoietic Cell Transplant Recipients
- (2010) Margaret Pollack et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis
- (2010) J. A. Brown et al. BLOOD
- How I treat adenovirus in hematopoietic stem cell transplant recipients
- (2010) C. A. Lindemans et al. BLOOD
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- (2010) Maiko Asakura et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion
- (2010) Martin Schmidt-Hieber et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients
- (2010) R.K. Avery et al. Transplant Infectious Disease
- Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
- (2010) Robin K. Avery et al. TRANSPLANTATION
- Synthesis and Early Development of Hexadecyloxypropyl-cidofovir: An Oral Antipoxvirus Nucleoside Phosphonate
- (2010) Karl Y. Hostetler Viruses-Basel
- Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy
- (2009) Carolyn E. Behrendt et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation
- (2009) Hirohisa Nakamae et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation
- (2009) Pau Montesinos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation
- (2009) Jill C. Beck et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
- (2009) W. Zhou et al. BLOOD
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience
- (2009) J L Piñana et al. BONE MARROW TRANSPLANTATION
- Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants
- (2009) B George et al. BONE MARROW TRANSPLANTATION
- The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients
- (2009) H C Buyck et al. BONE MARROW TRANSPLANTATION
- Cytomegalovirus‐Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation
- (2009) Karl S. Peggs et al. CLINICAL INFECTIOUS DISEASES
- Antiviral prophylaxis in haematological patients: Systematic review and meta-analysis
- (2009) Dafna Yahav et al. EUROPEAN JOURNAL OF CANCER
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus
- (2009) T. Allice et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) D. J. Winston et al. BLOOD
- Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation
- (2008) L-R Wang et al. BONE MARROW TRANSPLANTATION
- Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients
- (2008) G Gerna et al. BONE MARROW TRANSPLANTATION
- Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan
- (2008) Akira Tomonari et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant Recipients
- (2008) C. Gimeno et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Detection of CMV DNA: Is EDTA whole blood superior to EDTA plasma?
- (2008) Christoph Koidl et al. JOURNAL OF VIROLOGICAL METHODS
- Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation
- (2008) Z.Y. Lim et al. LEUKEMIA RESEARCH
- Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation with Alemtuzumab
- (2008) Won Kyung Song et al. OPHTHALMOLOGY
- Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir
- (2008) Sunwen Chou REVIEWS IN MEDICAL VIROLOGY
- Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials
- (2008) L. Demopoulos et al. TRANSPLANTATION PROCEEDINGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now